Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence
Related Articles
Anumana Joins Accelerating Medicines Partnership Heart Failure Program to Advance ECG-AI™ Research
Program provides access to real-world data to refine AI algorithms for earlier detection of complex heart conditionsOctober 24, 2024
Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension
CAMBRIDGE, Mass. – March 28, 2026 – Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled…March 28, 2026
Mayo Clinic AI algorithm proves effective at spotting early-stage heart disease in routine EKG data
FIERCE Biotech: An algorithm developed by the Mayo Clinic can significantly increase the number of cases of low ejection fraction caught in its earliest stages, when it’s still most treatable,…May 09, 2022
AI transforms smartwatch ECG signals into a diagnostic tool for heart failure
Mayo Clinic News Network: Two health tech advances are at the heart of a study published in Nature Medicine: an app and backend infrastructure to let patients remotely share smartwatch…November 14, 2022